Douglas Reed M.D. is 10% Owner at G1 Therapeutics, Inc. (GTHX). They have made 8 open-market trades across 4 companies since 2006, most recently 2018-05-30.
CIK 0001291262
2 open-market purchases totalling $3.0M since 2013, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GTHX | SELL | 2018-05-30 | 2018-06-01 | $48.00 | $38.4M | -1.1% | +4.3% | +37.9% |
| GTHX | SELL | 2018-05-21 | 2018-05-23 | $51.11 | $3.8M | -24.0% | -2.2% | +16.6% |
| GTHX | BUY | 2017-05-22 | 2017-05-24 | $15.00 | $2.0M | +8.4% | +5.4% | +2.3% |
| CLSD | SELL | 2017-01-17 | 2017-01-19 | $8.63 | $512K | -8.7% | -6.4% | -8.9% |
| TLOG | BUY | 2013-12-17 | 2013-12-19 | $7.00 | $1000K | -81.5% | +0.5% | +0.5% |
| DRAD | SELL | 2007-08-24 | 2007-08-27 | $3.05 | $92K | -7.2% | -2.8% | -2.8% |
| DRAD | SELL | 2007-05-24 | 2007-05-29 | $4.32 | $302K | -7.2% | -2.8% | -2.8% |
| DRAD | SELL | 2006-02-24 | 2006-03-07 | $3.97 | $111K | -7.2% | -2.8% | -2.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.